striato-thalamo-cortical loop, which is hypothesized to be dysfunctional in OCD. However, several adverse effects are associated with AC, most commonly cognitive functional impairments such as memory problems and executive dysfunction. 25, 26, 34 However, it is worth noting that very few studies have systematically assessed changes in cognitive performance following AC. 3, 7, 42 At the Karolinska Hospital in Stockholm between 1978 and 1990, Nyman et al. 25 observed 21 patients with extreme OCD treated with thermocapsulotomy. Another 8 OCD patients seen more recently served as a control group. At follow-up, all patients were examined with a comprehensive neuropsychological test battery including the Wechsler Adult Intelligence Scale-Revised, Controlled Oral Word Association Test, Swedish Claeson-Dahl Test, Rey Complex Figure Test , and the Wisconsin Card Sorting Test (WCST). In a subgroup of surgically treated patients who did not complete all subtests on the WCST, there was a significant positive correlation between time elapsed after capsulotomy and number of subtests completed on the WCST. Researchers found that patients with extreme OCD as a group perform in the lower to mildly impaired range on neuropsychological tests. In some patients, executive function was affected but restored over time.
Rück et al. 34 examined 25 OCD patients who had undergone AC between 1988 and 2000 at the Karolinska Institute in Stockholm, Sweden. Results of pre-and postoperative neuropsychological tests, including the Wechsler Adult Intelligence Scale-Revised, Controlled Oral Word Association Test, WCST, and simplified Six Elements Task, were recorded for 7 patients. The pre-and postoperative data from the WCST and Digit Span Test suggested more compromised executive function at the long-term followup. The study results suggested that clinical and cognitive improvement stagnate after 1 year postoperatively, and the authors concluded that there were no significant differences between the 1-year and the long-term follow-up ratings, implying that improvement was generally stable.
Taub et al. 42 At Gyula Nyírő Hospital in Budapest, Hungary, Csigó et al. 7 examined 10 patients with treatment-refractory OCD who were divided into 2 groups (surgical and nonsurgical) of 5 participants each. Ten neuropsychological tests were used to measure cognitive function. At the 2-year follow-up, the investigators found a significant increase in most of the neuropsychological test scores in both surgical (thermocapsulotomy) and nonsurgical groups. They observed intrusion errors only on the Category Fluency Test. The nonsurgical group showed better performance than the surgical group on only 3 tests: Trail Making Test B, Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) Attention Index, and RBANS Language Index. The clinical and neuropsychological improvements were more impressive in the surgical group.
At the Santa Paula Hospital in Brazil, Batistuzzo et al. 3 conducted, in the first phase of the trial, a double-blind randomized controlled trial (RCT) of gamma ventral capsulotomy (GVC) in 16 patients with refractory OCD. The secondary analysis phase included 17 patients: 8 from the active treatment group, 4 from the sham group who underwent surgery after the blind phase was over, and 5 patients from a previous open pilot study. A comprehensive neuropsychological evaluation of intellectual functioning, attention, verbal and visuospatial learning and memory, visuospatial perception, inhibitory control, cognitive flexibility, and motor functioning was performed at baseline and at the 1-year follow-up. In the RCT, visuospatial memory performance significantly improved in the active treatment group after GVC and remained stable in the sham group. There was no decline in cognitive or motor functioning after 1 year in the surgically treated patients. The authors concluded that improvement in certain neuropsychological domains, particularly visuospatial memory performance, occurred 1 year after GVC in patients with treatment-refractory OCD. Currently, there are no reliable conclusions regarding neuropsychological changes after AC. Most recent studies have shown that patients experience some degree of improvement in cognitive functioning domains such as intellectual functioning (IQ), verbal memory, visuospatial memory, and executive functioning. 3, 7, 42 However, given the lack of healthy control subjects in these studies, the degree and type of cognitive impairments experienced by patients before surgery, as well as the extent to which these impairments are improved by surgery, are not entirely clear. Moreover, few studies have analyzed the variations in cognition at different follow-up time points. Therefore, in the present study, we included a nonsurgical OCD group, as well as a healthy control group, each comprising 14 subjects. Our aim was to investigate changes in cognitive function over time following AC in patients with treatment-refractory OCD. We hypothesized that OCD patients would exhibit poorer cognitive performance than healthy controls at baseline but would improve over the 12 months after AC. Furthermore, we anticipated that OCD patients would exhibit normal performance levels on several cognitive tests.
Methods

Inclusion and Exclusion Criteria, Ethical Issues, and Demographics
Diagnoses were made by 2 psychiatrists using the criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV or DSM-5). The treatment-refractory nature of the illness was carefully defined by the following criteria: meeting the DSM-IV or DSM-5 criteria for a diagnosis of OCD; having undergone systematic treat-ment with at least 3 different trials of SSRIs and an adequate drug therapy duration of a minimum of 12 weeks; having participated in cognitive behavioral therapy (CBT) for more than 20 hours (or an inability to participate in CBT because of severe OCD symptoms); and having a less than 25% reduction in Yale-Brown Obsessive Compulsive Scale (Y-BOCS) scores after both drug therapy and CBT. 12 Inclusion criteria for the surgical OCD patients were as follows: an age between 18 and 60 years, a 5-year history of obsessive-compulsive symptoms causing substantial suffering and significantly reduced functioning, meeting the DSM-IV or DSM-5 criteria for the diagnosis of OCD, and disease identified as treatment refractory by the 2 aforementioned psychiatrists. Consent from both the patients and their families was required for surgical treatment. Patients with a history of head injury, posttraumatic amnesia, brain tumor, or other somatic disease that precluded surgery were excluded from the study, as were those who were unable to give informed consent, as determined via neuropsychological testing. 12 This study was approved by the institutional review board of the West China Hospital of Sichuan University Clinical Trials and Biomedical Ethics Committee. All patients signed informed consent forms.
Randomized surgical OCD patient selection was not possible due to ethical concerns; therefore, we performed a retrospective nonrandomized study. We selected 14 consecutive patients from a group of 38 treatment-refractory OCD patients who had undergone AC via thermocoagulation between 2007 and 2013 at the West China Hospital. To minimize the effects of confounding variables, we selected 14 age-, sex-, and Y-BOCS score-matched nonsurgical OCD patients who had been evaluated at the same center between 2008 and 2013. All surgical and 3 nonsurgical OCD patients were, based on the abovementioned criteria, diagnosed with treatment-refractory disease by the 2 aforementioned psychiatrists. Moreover, we included 14 age-and sex-matched healthy volunteers who had undergone the same neuropsychological examinations by the same psychiatrists between 2012 and 2014. The demographic characteristics of all 42 subjects and the clinical symptoms of the patients in the 2 OCD groups are shown in Table 1 . There were no differences among the 3 groups with respect to age (chi-square = 0.451, p = 0.798), education level (chi-square = 0.117, p = 0.943), sex (male/ female: 5/9, 5/9, 6/8), and handedness (all patients were right handed). The surgical and nonsurgical groups did not differ significantly regarding Y-BOCS scores (z = -0.554, p = 0.580) or hours of CBT (z = -0.184, p = 0.854) at baseline but did differ in terms of OCD duration (z = -3.441, p = 0.001) and SSRI treatment duration (z = -3.892, p = 0.000). Eight patients were unemployed, and 6 patients in the surgery group had previously attempted suicide.
Clinical Assessments and Neuropsychological Tests
All 42 subjects underwent face-to-face assessments performed by the 2 previously mentioned psychiatrists at our medical center at baseline, as well as at regular intervals during a 12-month follow-up. No surgical patients received any drugs or CBT during the 12-month follow-up period, except for 3 patients who received limited and discontinuous drug treatment because of limited postsurgical improvement. It was not possible to ensure that every patient in the nonsurgical group complied with the treatment regimens (in terms of medication dosages and CBT time) throughout the 12-month follow-up period; however, every nonsurgical patient received adequate dosages of SSRIs (one of which was clomipramine) and underwent CBT for more than 2 hours per week with the same therapist during the follow-up. We used the Y-BOCS 9 to assess obsessive-compulsive symptoms in the OCD patients at the indicated time points (baseline and 1, 3, 6, and 12 months after treatment). Patients were considered to be responsive to therapy if they had a Y-BOCS score reduction of 35% or more as compared with their baseline score. Given concerns regarding patient adherence to therapeutic regimens as well as their ability to complete complex comprehensive tests, we made the neuropsychological evaluation as simple as possible and used specific subtests. Each test session lasted approximately 50 minutes or less for each participant. The neuropsychological battery consisted of the following measures: Similarities and Block Design, which are subtests of the WASI; Immediate and Delayed Logical Memory and Immediate and Delayed Visual Reproduction, subtests of the WMS-R; and Corrects, Categories, Perseverative Errors, Nonperseverative Errors, and Errors, subtests of the WCST. The neuropsychological evaluations in the OCD patients were performed at the same time points as the Y-BOCS examinations (baseline and 1, 3, 6, and 12 months after treatment). The domains and functions for each subtest are shown in Table 2 . To minimize placebo effects, we used different versions of each subtest at different time points, if possible (for example, Logical Memory Tests A and B and Visual Reproduction Tests A, B, and C). For cognitive assessment in the healthy control group, we adopted follow-up intervals of 6 months. In addition, CT was performed 1 day after surgery in the surgical group and MRI was performed 3 months after surgery to minimize the effects of early edema or bleeding on imaging results. Functional diffusion tensor imaging (1 day before surgery and 3 and 6 months after surgery) and PET/CT (1 day before surgery and 6 and 12 months after surgery) were performed in 14 surgical OCD patients to evaluate changes in cerebral white matter fiber and metabolism. Representative MRI results from 3 months after surgery are shown in Fig. 1 .
Surgical Technique of AC
For optimal targeting, MR images without fixation of the head frame were obtained the day before surgery for preplanning. A 3-T Trio Unite MRI system (Siemens AG) was used with T1-weighted and T2-weighted spin-echo sequences in the axial and coronal planes. Slice thickness was 2 mm with an interval gap of 0.02 mm. The preplanning procedure was completed using the SurgiPlan workstation (version 2.1, Elekta Instruments AB). On the day of surgery, a Leksell model G head frame (Elekta Instruments AB) was positioned on the skull parallel to the anterior commissure-posterior commissure line with the patient under local anesthesia. Repeat MRI with the same parameters applied in the preplanning scanning was performed using a 1.5-T Sonata Unite MRI system (Siemens AG). With the aid of the SurgiPlan workstation, the pre- scanned images were coregistered with the images using location markers. The coordinates of the target and the angles of electrode penetration were calculated. Lesion targets were located 14 mm anterior and 18 mm lateral to the anterior commissure and 5 mm below the anterior commissure-posterior commissure plane. Under the guidance of the Leksell multifunctional stereotactic operation system (Elekta Instruments AB), we inserted the electrode into the lesion target according to the calculated coordinates. Test stimulation generated by the Elekta neurostimulator at both high (130 Hz) and low (5 Hz) frequency was performed to verify the target of the electrode. Next, lesions were produced using the Elekta neurostimulator at 75°C for 60 seconds each. The length of the lesions on both sides was 12-14 mm.
Data Analysis
All data were analyzed using SPSS software (SPSS 19.0 for Windows, IBM Corp.). Considering the small sample size and the particularly nonnormal distribution of the data, we used nonparametric tests. Demographic characteristics and baseline clinical features were compared between the OCD and control groups using the Kruskal-Wallis test and the Mann-Whitney U-test. Repeated measures ANOVAs were performed using "time" (baseline and 1, 3, 6, and 12 months after surgery) as the within-subjects factor in both the surgical and nonsurgical groups. Repeated measures ANOVAs were performed using "time" (baseline and 6 and 12 months) as the within-subjects factor in the healthy control group. Wilcoxon signed-rank tests were used as post hoc tests to identify the time points at which the test scores were significantly different from those measured at baseline. We compared the scores of the surgical group with those of the nonsurgical group using repeated measures of the Mann-Whitney U-test at each time point. Finally, the effect of clinical symptom changes on neuropsychological performance was analyzed using Spearman's correlations to compare delta scores on the Y-BOCS and neuropsychological variables at the 12-month time point. All figures in this paper were created in GraphPad Prism 5. 
Results
Clinical Symptom Results
Repeated measures ANOVA was performed on the Y-BOCS scores during the follow-up period (Tables 3 and  4) . Patients who had undergone surgery exhibited clinical symptom improvements postoperatively. Significant decreases in the Y-BOCS scores were observed (c 2 = 19.154, p = 0.000). Wilcoxon signed-rank tests were performed to determine the intervals at which these changes were statistically significant. As early as 1 month after surgery, the Y-BOCS scores showed significant improvement (z = -3.297, p = 0.001) and these improvements appeared to be consistent. At the 12-month time point, the mean Y-BOCS score (10.21) was significantly less than the mean preoperative score (29.21; z = -3.235, p = 0.001). As shown in Fig. 2 , surgical patients 8 and 9 (S8 and S9) exhibited Y-BOCS score reductions of less than 35% compared with their baseline scores. Surgical patient 8 resumed drug therapy 10 months after surgery, and S9 was lost to follow-up 15 months after surgery. Surgical patient 14 experienced symptom recurrence 8 months after surgery and underwent a second surgery 13 months after the first. But decreases in Y-BOCS scores were noted in the nonsurgical group as well (c 2 = 5.794, p = 0.000). Repeated measures Mann-Whitney U-tests were used to compare the Y-BOCS scores of surgical patients with those of the nonsurgical patients. Scores in the surgical group (after 1 month: z = -2.809, p = 0.005; after 12 months: z = -2.094, p = 0.036) were significantly lower at each time point (1, 3, 6 , and 12 months after surgery) except at baseline.
Neuropsychological Testing Results in the Surgical Group
Repeated measures ANOVA was also performed on all neuropsychological test scores during follow-up in the surgical group. As shown in Table 3 
Neuropsychological Testing Results in the Nonsurgical and Healthy Control Groups
Repeated measures ANOVA was also performed on all neuropsychological test scores during the follow-up period in the nonsurgical and healthy control groups. As shown in Tables 4 and 5 formed to compare the scores of the surgical group with those of the nonsurgical and healthy control groups at baseline and at the 12-month time point. As shown in Fig. 4 , at baseline, both the surgical and the nonsurgical groups 
Correlation Between Neuropsychological Changes and Symptom Improvements in the Surgical Group
Spearman's correlation tests were performed to compare delta scores pertaining to clinical symptom changes with neuropsychological variables in the surgical group. As shown in Fig. 6 , of all the delta scores recorded between baseline and 12 months after surgery in the surgical group, only the delta score for the Delayed Logical 
Side Effects in Surgical Patients
Most of the adverse events experienced by patients were transient. Two patients (S10, S14) experienced incontinence for the first 2-3 days after surgery. Six patients (S2, S3, S6, S9, S10, S11) experienced hypersomnia for a few days after surgery. Six patients (S1, S4, S7, S8, S9, S14) exhib- ited various degrees of childish behavior, but most of them experienced symptom resolution within 3 months, and 1 patient (S7) experienced complete symptom resolution at 10 months after surgery. Four patients (S4, S7, S10, S12) experienced occasional visual hallucinations during the 1st month after surgery. All patients experienced symptom remission upon receiving appropriate pharmacological therapy. Two patients exhibited symptoms of sexual disinhibition; one (S9) experienced symptom resolution 6 months after surgery, while the other (S14) began exhibiting symptoms of severe sexual disinhibition 8 months after surgery, as well as OCD symptom recurrence. Ultimately, this patient underwent a second surgery 13 months after her first. Three patients (S7, S13, S14) exhibited personality changes, including lack of interest, inappropriate laughter, and decreased motivation, which proved to be permanent at the 12-month time point. Weight gain, which has often been reported in similar studies, was not observed in this study.
Discussion
Findings in the present study suggest that improvements in clinical symptoms can appear as early as 1 month after surgery and can be sustained thereafter. Eleven (78.6%) of 14 patients responded to therapy within 12 months. Our results are consistent with those of previous studies. 16, 21, 28 In our limited experience, AC is effective at reducing OCD symptoms. However, this procedure is associated with several (reversible) adverse effects, such as personality changes, childish behavior, visual hallucinations, incontinence, hypersomnia, and sexual disinhibition.
Interestingly, the nonsurgical OCD group exhibited appropriate improvements in the Y-BOCS scores. This group received systematic drug therapy and CBT during the 12-month follow-up period, which may explain these improvements. According to several previous studies, both SSRIs and CBT are effective at reducing symptoms in patients with treatment-refractory OCD. 2, 31 Furthermore, although the 2 OCD groups matched in terms of their initial Y-BOCS scores, they did not match in terms of baseline obsessive-compulsive symptom duration or SSRI treatment duration, as both durations were shorter in the surgical OCD group, which may explain the above results. However, the placebo effect of multiple visits may have also affected our results, an unavoidable and important shortcoming of this study.
Our goal in the present study was to investigate changes in OCD patients' cognitive function over a 12-month postoperative follow-up period. Thus, our study was divided into 3 stages. First, we defined the cognitive deficits that characterize treatment-refractory OCD. Next, we investigated how cognitive function changes with time in OCD patients after surgery and compared these changes with those experienced by nonsurgical OCD patients and healthy controls. Lastly, we explored how AC modifies cognitive performance in treatment-refractory OCD patients and determined whether posttreatment cognitive improvements are related to OCD symptom alleviation. 
Cognitive Deficits in OCD Patients Before Surgery
A large number of studies on the neuropsychological deficits that characterize OCD have been conducted. In the past 25 years, researchers have explored several cognitive domains, including memory (for example, verbal memory 4,37 and visual and spatial memory 19, 29, 32, 33 ) and executive function (for example, set shifting, 1, 22, 23, 27 fluency, 13, 19, 39 and decision making 5, 14, 35 ). The majority of these studies have noted some degree of impairment in nonverbal memory, visuospatial skills, and visual and selective attention among OCD patients. 6, 10, 24, 36, 38, 41 We found that both surgical and nonsurgical OCD groups exhibited significantly impaired visuospatial processing, visual memory, verbal memory, and executive function at baseline as compared to healthy controls. These findings are consistent with those of most previous reports. Interestingly, before surgery the surgical group exhibited more severe executive function impairment than the nonsurgical group. As shown in Table 1 , these 2 groups exhibited no significant differences in sex, age, education level, CBT duration, or Y-BOCS scores; however, there were significant differences in disease duration and SSRI treatment duration. This suggests that the degree of impairment in several advanced cognitive functions (such as executive function) is related to OCD symptom duration or drug treatment duration rather than symptom severity.
Changes in Cognitive Function as a Result of AC for Treatment-Refractory OCD
We noted mild impairments in performance on most neuropsychological tests, particularly the Immediate Logical Memory and Correct subtests, 1 month after surgery compared with baseline, which we attributed to the destructive nature of AC. However, this phenomenon proved to be transient. Thereafter, visuospatial processing, visual memory, and verbal memory performance improved significantly compared with baseline. Moreover, these improvements persisted such that there were no significant differences between surgical patients and healthy controls at the 12-month follow-up. However, although the level of executive function exhibited by the surgical group eventually reached that exhibited by the nonsurgical group, it remained poorer than that exhibited by the healthy control group at 12 months after surgery. Importantly, neuropsychological improvements were observed across the following domains: visuospatial processing, visual memory, verbal memory, and executive function. These findings are in accordance with those of several recent studies. 3, 7, 42 However, we did not observe any significant differences in abstract verbal reasoning ability (Similarities subtest) among the 3 groups before or after surgery. This finding is inconsistent with the results of Taub et al., 42 who reported increases in the Similarities subtest scores in 4 of 5 refractory OCD patients after VC/VS gamma capsulotomy.
Verbal Memory, Visual Memory, and Visuospatial Skill Changes in OCD Patients After AC
In our study, verbal memory, visual memory, and visuospatial skills improved at the 3-month follow-up compared with baseline and reached normal levels by the last followup. Regarding verbal memory, our results are consistent with those of the following 2 studies. Taub et al. 42 reported improvements in Immediate and Delayed Logical Memory in 4 of 5 and 5 of 5 refractory OCD patients, respectively, following VC/VS gamma capsulotomy. However, that study included a small sample of participants who were evaluated at different time points. Batistuzzo et al. 3 also noted a significant improvement in Immediate and Delayed Logical Memory test results in all OCD patients at 1 year after VC/VS gamma capsulotomy. However, that study did not include a healthy control group.
Regarding visual memory and visuospatial skill, Nyman et al. 25 found that patients performed no better than the control patients on the Rey Complex Figure Test (testing visuospatial memory abilities) after capsulotomy. Taub et al. 42 noted score increases on the Block Design subtest in only 2 of 5 refractory OCD patients after VC/VS gamma capsulotomy. Kim et al. 13 showed that immediate recall on the Rey Complex Figure Test improved more in OCD patients than in control subjects over a period of 4 months. Batistuzzo et al. 3 found that visuospatial memory performance improved significantly in an actively treated group (n = 8) after GVC radiosurgery. Our visuospatial memory subtest results are consistent with those of Batistuzzo et al. 3 and Kim et al. 13 but are inconsistent with those of Nyman et al. 25 and Taub et al. 42 It is well known that the prefrontal cortex is closely associated with memory. In particular, visuospatial memory is mediated by the orbitofrontal cortex and closely connected to the limbic area. 8, 15, 30 Additionally, visuospatial memory deficits are often reported in OCD patients. A large body of research supports the idea that orbitofrontalstriatal circuits are a neuropathophysiological mechanism underlying OCD development. A recent meta-analysis of neuropsychological data pertaining to OCD patients indicated that visuospatial memory exhibits the most consistent cognitive improvements in OCD patients after treatment. 40 It is possible that postoperative improvements in verbal memory, visual memory, and visuospatial skills occur secondary to improvements in obsessive-compulsive symptoms. Upon symptom improvement, patient concentration levels can spontaneously improve, resulting in gradual improvements in verbal memory and visuospatial memory. However, we noted similar improvements in 2 (S8, S9) patients without therapy response. 
Executive Function Changes in OCD Patients After AC
Several studies have reported that patients exhibit impaired performance in the Perseverative Errors and Responses categories on the WCST after Nyman and Mindus 26 noted that 3 of 5 patients presented with more perseverative responses 1 year postcapsulotomy. Rück et al. 34 found that limited numbers of patients who had undergone preoperative and postoperative neuropsychological evaluations had poorer postoperative WCST results and concluded that capsulotomy induced mild executive function impairment in these patients by the long-term follow-up.
However, several studies have reported contrasting findings. Nyman et al. 25 noted that in a subgroup of capsulotomy patients who did not complete all 6 categories of the WCST, the number of years elapsed after capsulotomy correlated positively with the number of categories completed. Csigó et al. 7 noted improvements in the majority of the abovementioned cognitive functions after AC, including improvements in several executive functions, such as set shifting (Stroop Test, California Sorting Test) and decision making (Iowa Gambling Test), during a 24-month follow-up. Batistuzzo et al. 3 found that an actively treated group demonstrated significant improvements in WCST performance compared with a sham-treated group during a 12-month RCT.
Our results partially support those of previous studies. 3, 7, 25 Our data indicate that executive function improved by the 6-month and 12-month follow-ups, albeit at a slower rate than the OCD symptoms and memory. However, executive function did not reach a normal level at the 12-month time point. We surmised that advanced cognitive functions, such as executive functions, may require longer recovery periods. This hypothesis is supported by the findings of Nyman et al., 25 who noted that the number of years elapsed after capsulotomy correlates positively with the number of categories completed on the WCST. Therefore, we will subject surgically treated patients to a much longer follow-up period in future studies. We believe that executive function performance can reach near-normal levels within a few years after AC.
Variations in Cognitive Function Between Surgical and Nonsurgical Patients at the 12-Month Follow-Up
The surgical group exhibited greater improvements in verbal memory, visual memory, visuospatial skills, and executive function than the nonsurgical group at the 12-month time point. These findings indicate that AC may be more effective than CBT or SSRIs at improving cognitive deficits in treatment-refractory OCD patients. However, the 2 groups of OCD patients in our study differed significantly regarding disease duration and SSRI treatment duration. Therefore, caution is warranted regarding the interpretation of our results.
How Does AC Facilitate Cognitive Profile Changes in
Treatment-Refractory OCD Patients?
Milad and Rauch 20 described the different components of the so-called cortico-striato-thalamo-cortical pathways commonly implicated in the psychopathology of OCD.
These pathways include the following 3 loops: an affective circuit, reflecting affective and reward processing: "anterior cingulate cortex/ventromedial prefrontal cortexnucleus accumbens-thalamus-cortex"; a dorsal cognitive circuit, reflecting working memory and executive function: "dorsolateral prefrontal cortex-dorsal caudate-thalamus-cortex"; and a ventral cognitive circuit, reflecting motor and response inhibition: "anterolateral orbitofrontal cortex-putamen-thalamus-cortex."
These loops interact with and are linked to one another. Studies have implicated the affective and ventral cognitive circuits in OCD. As a result, capsulotomy, cingulotomy, and nucleus accumbens deep brain stimulation procedures have been widely applied in the management of treatmentrefractory OCD and have often successfully attenuated obsessive-compulsive symptoms. Given the interconnectedness of these 3 loops, we hypothesize that OCD-related cognitive deficits are caused by the influence of the affective and ventral cognitive circuits and that targeting the internal capsule may affect the connections between the orbitofrontal cortex or ventromedial prefrontal cortex and the thalamus, interrupting the hyperfunctional frontal-striatal circuits associated with the pathophysiology of OCD, restoring dorsal cognitive circuit function 18 and facilitating improvements not only in obsessive-compulsive symptoms but also in memory and executive function after AC. Additionally, because the dorsal caudate is located medial and ventral to the anterior limb of the internal capsule, it is possible that the memory and executive function impairments reported for previous studies 26, 34 are caused by large lesions resulting in damage to the dorsal cognitive circuit. Thus, accurate target location is vital to the success of AC. In our limited experience, we have found that smaller lesions are associated with lower risks of adverse effects and that lateral or medial lesions involving the anterior limb of the internal capsule are associated with better results. These findings are consistent with those of Rück et al., 34 who found that OCD symptom reduction may be facilitated by reducing lateral lesion extension and that adverse effects may be minimized by reducing medial and posterior lesion extension. Taub et al. 42 found that smaller, more ventrally located internal capsule lesions may have a different impact on cognitive outcomes. Lastly, we hypothesize that the projections of the dorsal cognitive circuit may pass close to the posterior region of the anterior limb of the internal capsule. This idea warrants further research, possibly diffusion tensor imaging-based research. Furthermore, we believe that improvements in cognitive performance are facilitated by improvements in obsessive-compulsive symptoms rather than interruptions of abnormal circuitry, as postulated by Batistuzzo et al. 3 The Delayed Logical Memory subtest results exhibited a significant correlation with the Y-BOCS results in this study and may support the abovementioned idea. However, we did not note this outcome on other tests, perhaps because the sample was relatively small. Further research is warranted to elucidate the exact mechanisms underlying neuropsychological improvements post-OCD surgery.
Study Limitations
The findings of this study should be interpreted with caution for several reasons. First, the sample was relatively small (only 14 subjects in each group). Second, the 12-month follow-up period may not have been sufficient to observe improvements in specific cognitive functions, such as executive function. Third, given our strict inclusion and exclusion criteria, our results may not be generalizable to other populations. Fourth, we used relatively few neuropsychological tests, which may not have reflected all the cognitive deficits in our sample. Last, our results were clearly influenced by a placebo effect, particularly our Y-BOCS score results, most likely because of our use of short follow-up time intervals, such as the interval between the 1-and 3-month time points. To attenuate the short-term placebo effect exerted by repeated tests, we considered evaluating patients every 3 months after surgery. However, given our experience, we determined that the 1-month time point is important with respect to changes in OCD patient symptoms and cognitive function and thus included this time point in our study. We also tried to use different versions of specific OCD symptom scales at different time points to minimize the placebo effect; however, no appropriate scales are available to replace the Y-BOCS. Therefore, we used this scale at each time point, which means that the 2 OCD groups experienced the same placebo effect. We used symptom and cognitive function analyses to determine if the placebo effect significantly influenced our results. We surmised that if the placebo effect had been significant, the results noted in the 2 OCD groups at each time point would be similar because the initial symptoms and cognitive function deficits noted in these groups were similar. However, we found that the 2 OCD groups exhibited significant differences with respect to symptoms and cognitive function, indicating that the placebo effect did not significantly influence our results. Nonetheless, we were unable to determine the exact degree to which the placebo effect did influence our results. This was an important shortcoming of our study, although we do not believe that the placebo effect significantly affected its outcome. In future studies, we will attempt to use follow-up intervals of 3 months, 6 months, or longer, as well as different versions of the same performance tests, to minimize the placebo effect. Furthermore, there were significant differences between the surgical and nonsurgical OCD groups (disease duration and SSRI treatment duration) at baseline, which may have influenced the test performance of each group. Despite these limitations, we believe that our findings are both clinically and scientifically valuable because of the very small number of patients who received the treatment described herein. In the future, we will expand our sample size, use more neuropsychological tests, and evaluate patients over a much longer follow-up period.
